4f7b
From Proteopedia
Line 1: | Line 1: | ||
- | + | {{STRUCTURE_4f7b| PDB=4f7b | SCENE= }} | |
+ | ===Structure of the lysosomal domain of limp-2=== | ||
- | The | + | ==Disease== |
+ | [[http://www.uniprot.org/uniprot/SCRB2_HUMAN SCRB2_HUMAN]] Unverricht-Lundborg disease;Gaucher disease type 1;Action myoclonus - renal failure syndrome. The disease is caused by mutations affecting the gene represented in this entry. Genetic variants in SCARB2 can act as modifier of the phenotypic expression and severity of Gaucher disease. | ||
- | + | ==Function== | |
+ | [[http://www.uniprot.org/uniprot/SCRB2_HUMAN SCRB2_HUMAN]] Acts as a lysosomal receptor for glucosylceramidase (GBA) targeting.<ref>PMID:18022370</ref> | ||
- | + | ==About this Structure== | |
+ | [[4f7b]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4F7B OCA]. | ||
+ | |||
+ | ==Reference== | ||
+ | <references group="xtra"/><references/> | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Arrowsmith, C H.]] | ||
+ | [[Category: Bountra, C.]] | ||
+ | [[Category: Dhe-Paganon, D.]] | ||
+ | [[Category: Edwards, A M.]] | ||
+ | [[Category: Neculai, D.]] | ||
+ | [[Category: Neculai, M.]] | ||
+ | [[Category: Pizzaro, J.]] | ||
+ | [[Category: Ravichandran, M.]] | ||
+ | [[Category: SGC, Structural Genomics Consortium.]] | ||
+ | [[Category: Atherosclerosis]] | ||
+ | [[Category: Cell adhesion]] | ||
+ | [[Category: Endocytosis]] | ||
+ | [[Category: Lipid transport]] | ||
+ | [[Category: Lipoprotein]] | ||
+ | [[Category: Scavenger receptor]] | ||
+ | [[Category: Sgc]] | ||
+ | [[Category: Structural genomic]] | ||
+ | [[Category: Structural genomics consortium]] |
Revision as of 06:36, 10 October 2013
Contents |
Structure of the lysosomal domain of limp-2
Disease
[SCRB2_HUMAN] Unverricht-Lundborg disease;Gaucher disease type 1;Action myoclonus - renal failure syndrome. The disease is caused by mutations affecting the gene represented in this entry. Genetic variants in SCARB2 can act as modifier of the phenotypic expression and severity of Gaucher disease.
Function
[SCRB2_HUMAN] Acts as a lysosomal receptor for glucosylceramidase (GBA) targeting.[1]
About this Structure
4f7b is a 6 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- ↑ Reczek D, Schwake M, Schroder J, Hughes H, Blanz J, Jin X, Brondyk W, Van Patten S, Edmunds T, Saftig P. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell. 2007 Nov 16;131(4):770-83. PMID:18022370 doi:http://dx.doi.org/10.1016/j.cell.2007.10.018
Categories: Homo sapiens | Arrowsmith, C H. | Bountra, C. | Dhe-Paganon, D. | Edwards, A M. | Neculai, D. | Neculai, M. | Pizzaro, J. | Ravichandran, M. | SGC, Structural Genomics Consortium. | Atherosclerosis | Cell adhesion | Endocytosis | Lipid transport | Lipoprotein | Scavenger receptor | Sgc | Structural genomic | Structural genomics consortium